Perceptive Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-23,800
Closed -$10.7M 133
2018
Q3
$10.7M Sell
23,800
-12,846
-35% -$5.06M 0.29% 55
2018
Q2
$15M Sell
36,646
-295,803
-89% -$107M 0.39% 50
2018
Q1
$96.7M Buy
332,449
+117,449
+55% +$29.8M 2.71% 9
2017
Q4
$40.3M Buy
215,000
+163,271
+316% +$30.5M 1.34% 18
2017
Q3
$8.72M Buy
+51,729
New +$7.82M 0.33% 53
2017
Q2
Sell
-85,000
Closed -$10.6M 167
2017
Q1
$10.6M Buy
85,000
+84,891
+77,882% +$9.84M 0.61% 39
2016
Q4
$12K Sell
109
-63,181
-100% -$7.32M ﹤0.01% 161
2016
Q3
$8.14M Buy
63,290
+48,590
+331% +$5.82M 0.53% 47
2016
Q2
$1.61M Buy
14,700
+5,000
+52% +$497K 0.11% 92
2016
Q1
$920K Buy
+9,700
New +$819K 0.08% 104
2015
Q3
Sell
-10,000
Closed -$657K 191
2015
Q2
$657K Hold
10,000
0.04% 127
2015
Q1
$716K Buy
+10,000
New +$543K 0.06% 109
2014
Q4
Sell
-25,000
Closed -$789K 170
2014
Q3
$621K Buy
+25,000
New +$633K 0.06% 92
2014
Q2
Sell
-5,000
Closed -$130K 147
2014
Q1
$130K Buy
+5,000
New +$138K 0.01% 118

Other funds holding ABMD

Perceptive Advisors's ABMD Position: Q4 2018 in Review

Perceptive Advisors sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 23,800 shares — an estimated $10.7M sold.

Perceptive Advisors first reported a position in ABMD in Q1 2014 and held it in 14 quarters. The position peaked at $96.7M in Q1 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Perceptive Advisors reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Perceptive Advisors sold 23,800 Abiomed Inc shares in Q4 2018, an estimated $10.7M.
  • Perceptive Advisors first reported a position in Abiomed Inc in Q1 2014 and held it in 14 quarters.
  • Perceptive Advisors's Abiomed Inc position peaked at $96.7M in Q1 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Perceptive Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.